MedPath

Treatment Of Oligohydramnios

Phase 2
Conditions
Health Condition 1: O410- Oligohydramnios
Registration Number
CTRI/2024/05/067475
Lead Sponsor
Govt Nizamia Tibbi College and General Hospital Charminar Hyderabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Both primi gravida and multigravida

Age 18-35 years

Gestational age 26 to 36 weeks

Patients with AFI more than 6 cms to less than 10 cms

Exclusion Criteria

Pregnant women age more than 35 years

AFI less than 6 cms

Pre eclampsia

Uncontrolled PIH

Pregnant women systemic diseases like GDM, renal diseases, cardiac diseases, tuberculosis and etc

Patients with bad obstetric history

Foetal anomalies, leaking amniotic fluid

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase the AFI and reduce the fetal complicationsTimepoint: Each patient give the oral medication of 20 days and check the AFI
Secondary Outcome Measures
NameTimeMethod
To reduce maternal and fetal mortality and morbidity rateTimepoint: Each patients outcome depends on 20 days of oral medication and assessment will be done by AFI
© Copyright 2025. All Rights Reserved by MedPath